Replimune Group, Inc. - Common Stock (REPL)

An investigational treatment, used in combination with another cancer medication, took an important step forward after several setbacks.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.

Let's dive into the action on the US markets on Monday. Here are the most active stocks that are driving the market today.

Curious to know what's happening on the US markets in the middle of the day on Monday? Join us as we explore the top gainers and losers in today's session.

Shares of Replimune Group are rising Monday after the clinical stage biotechnology company shared an important regulatory update.

Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

As we await the opening of the US market on Monday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

The biotech's recent meeting with FDA officials continued to resonate.

The fate of a once-promising cancer treatment now looks uncertain at best.

Looking for insights into the US markets one hour before the close of the markets on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Curious to know what's happening on the US markets in the middle of the day on Thursday? Join us as we explore the top gainers and losers in today's session.

In today's session, there are notable price gaps in the US markets on Thursday. Take a closer look at the stocks that are gap up and gap down.